Verici Dx (LON:VRCI) Stock Price Up 7.2% – What’s Next?

Verici Dx plc (LON:VRCI)’s share price traded up 7.2% during trading on Tuesday . The stock traded as high as GBX 0.67 ($0.01) and last traded at GBX 0.67 ($0.01). 1,920,448 shares traded hands during mid-day trading, an increase of 47% from the average session volume of 1,309,116 shares. The stock had previously closed at GBX 0.63 ($0.01).

Verici Dx Price Performance

The company has a 50-day moving average of GBX 0.55 and a two-hundred day moving average of GBX 1.19. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49. The stock has a market capitalization of £10.59 million, a PE ratio of -28.00 and a beta of 1.59.

Verici Dx Company Profile

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.